Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,895 | 110 | 77.4% |
| Education | $553.51 | 6 | 22.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $450.00 | 1 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $259.09 | 14 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $234.89 | 12 | $0 (2019) |
| Relypsa, Inc. | $177.51 | 12 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $160.76 | 9 | $0 (2024) |
| Shire North American Group Inc | $153.56 | 7 | $0 (2018) |
| AKEBIA THERAPEUTICS INC | $140.82 | 7 | $0 (2022) |
| Keryx Biopharmaceuticals, Inc. | $134.91 | 5 | $0 (2018) |
| OPKO Pharmaceuticals, LLC | $127.25 | 9 | $0 (2020) |
| Genentech USA, Inc. | $99.80 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.08 | 3 | Vifor Pharma, Inc. ($17.06) |
| 2023 | $41.94 | 3 | Horizon Therapeutics plc ($29.02) |
| 2022 | $130.29 | 7 | Mallinckrodt Hospital Products Inc. ($26.56) |
| 2021 | $509.68 | 5 | Intuitive Surgical, Inc. ($450.00) |
| 2020 | $142.62 | 9 | Advanced Respiratory, Inc ($36.95) |
| 2019 | $373.16 | 21 | AKEBIA THERAPEUTICS INC ($98.87) |
| 2018 | $650.71 | 38 | Otsuka America Pharmaceutical, Inc. ($132.00) |
| 2017 | $569.04 | 30 | Shire North American Group Inc ($122.59) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 06/21/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: KRYSTEXXA | ||||||
| 05/01/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: KRYSTEXXA | ||||||
| 04/20/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Nephrology | ||||||
| 08/15/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: KRYSTEXXA | ||||||
| 06/29/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Nephrology | ||||||
| 06/02/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/09/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/28/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 09/23/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO, ZINPLAVA | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/10/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $14.86 | General |
| 04/16/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $450.00 | General |
| Category: SURGERY | ||||||
| 03/18/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Hyperkalemia | ||||||
| 09/21/2020 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Airway Clearance Device | ||||||
| 06/23/2020 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Airway Clearance Device | ||||||
| 02/28/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: NEPHROLOGY | ||||||
| 02/06/2020 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Airway Clearance Device | ||||||
| 02/04/2020 | MAYNE PHARMA INC. | DORYX (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: DERMATOLOGY | ||||||
| 01/29/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $12.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,681 | 6,399 | $2.0M | $274,708 |
| 2022 | 38 | 2,971 | 5,180 | $808,685 | $224,484 |
| 2021 | 43 | 5,345 | 10,030 | $1.2M | $333,867 |
| 2020 | 41 | 6,307 | 12,745 | $1.2M | $316,246 |
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 39 | 251 | $491,860 | $65,634 | 13.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 183 | 512 | $338,565 | $45,820 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 237 | $166,388 | $20,252 | 12.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 77 | 364 | $125,165 | $16,610 | 13.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 115 | $113,346 | $14,527 | 12.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 60 | $97,589 | $13,109 | 13.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 79 | 349 | $92,555 | $12,253 | 13.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 197 | 296 | $73,313 | $11,787 | 16.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 82 | 85 | $81,937 | $10,985 | 13.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 63 | 275 | $71,973 | $9,736 | 13.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 47 | $55,568 | $7,454 | 13.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 173 | 242 | $42,979 | $6,936 | 16.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 52 | 102 | $40,582 | $5,344 | 13.2% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 153 | 205 | $22,780 | $3,637 | 16.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 39 | 109 | $23,688 | $3,243 | 13.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 199 | 315 | $19,958 | $3,194 | 16.0% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 19 | 19 | $27,153 | $3,030 | 11.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 238 | 378 | $17,622 | $2,829 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 192 | 264 | $4,752 | $2,205 | 46.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 242 | 362 | $11,028 | $2,028 | 18.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 117 | 117 | $11,737 | $1,964 | 16.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 238 | 358 | $11,127 | $1,800 | 16.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 18 | 18 | $10,620 | $1,460 | 13.7% |
| 84100 | Phosphate level | Office | 2023 | 194 | 301 | $8,560 | $1,370 | 16.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 32 | $8,319 | $1,140 | 13.7% |
About Dr. Mandeep Grewal, MD
Dr. Mandeep Grewal, MD is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447256862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mandeep Grewal, MD has received a total of $2,449 in payments from pharmaceutical and medical device companies, with $31.08 received in 2024. These payments were reported across 116 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($1,895).
As a Medicare-enrolled provider, Grewal has provided services to 18,304 Medicare beneficiaries, totaling 34,354 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 06/21/2005
- Last Updated 05/14/2009
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1447256862
Products in Payments
- Da Vinci Surgical System (Device) $450.00
- ACTHAR (Biological) $285.65
- Veltassa (Drug) $177.51
- Auryxia (Drug) $152.13
- SAMSCA (Drug) $148.29
- LOKELMA (Drug) $135.38
- GATTEX (Drug) $135.04
- AURYXIA (Drug) $123.60
- Rayaldee (Drug) $113.06
- Rituxan (Biological) $99.80
- JYNARQUE (Drug) $86.60
- Velphoro (Drug) $57.64
- BENLYSTA (Biological) $53.48
- KRYSTEXXA (Biological) $43.33
- Bidil (Drug) $38.89
- The Vest System Model 105 Home Care (Device) $36.95
- NATPARA (Drug) $32.55
- ENTRESTO (Drug) $23.33
- PURIFIED CORTROPHIN GEL (Drug) $22.54
- Parsabiv (Drug) $19.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Claude Galphin, Md, MD
Nephrology — Payments: $2,379